Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Rocco

Showing results (161-170 of 214) with videos related to

Pageof 22
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 28, 2006
Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) StudyYue-Harn Ng, Klemens B Meyer, John W Kusek, et al.
Kidney International|December 14, 2006
Frequent Hemodialysis Network (FHN) randomized trials: study designR S Suri, A X Garg, G M Chertow, et al.
The American Journal of Medicine|March 15, 2002
Potential cost savings of erythropoietin administration in end-stage renal diseaseDenise M Hynes, Kevin T Stroupe, Joel W Greer, et al.
Journal of the American Society of Nephrology : JASN|November 26, 2003
Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO studyAlfred K Cheung, Nathan W Levin, Tom Greene, et al.
Kidney & Blood Pressure Research|October 13, 2021
The Predialysis Serum Sodium Level Modifies the Effect of Hemodialysis Frequency on Left-Ventricular Mass: The Frequent Hemodialysis Network TrialsJochen G Raimann, Christopher T Chan, John T Daugirdas, et al.
Blood Purification|January 23, 2016
The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network TrialsJochen G Raimann, Christopher T Chan, John T Daugirdas, et al.
Kidney International|May 17, 2013
JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathyJasmin Divers, Marina Núñez, Kevin P High, et al.
Journal of the American Society of Nephrology : JASN|December 31, 2005
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO studyAlfred K Cheung, Michael V Rocco, Guofen Yan, et al.
Kidney International|May 10, 2016
APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal diseaseLijun Ma, Carl D Langefeld, Mary E Comeau, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2020
Relationship between measured and prescribed dialysate sodium in haemodialysis: a systematic review and meta-analysisJack Kit-Chung Ng, Brendan Smyth, Mark R Marshall, et al.
Pageof 22

Showing results (161-170 of 214) with videos related to

Sort By:
Pageof 22
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 28, 2006
Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) StudyYue-Harn Ng, Klemens B Meyer, John W Kusek, et al.
Kidney International|December 14, 2006
Frequent Hemodialysis Network (FHN) randomized trials: study designR S Suri, A X Garg, G M Chertow, et al.
The American Journal of Medicine|March 15, 2002
Potential cost savings of erythropoietin administration in end-stage renal diseaseDenise M Hynes, Kevin T Stroupe, Joel W Greer, et al.
Journal of the American Society of Nephrology : JASN|November 26, 2003
Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO studyAlfred K Cheung, Nathan W Levin, Tom Greene, et al.
Kidney & Blood Pressure Research|October 13, 2021
The Predialysis Serum Sodium Level Modifies the Effect of Hemodialysis Frequency on Left-Ventricular Mass: The Frequent Hemodialysis Network TrialsJochen G Raimann, Christopher T Chan, John T Daugirdas, et al.
Blood Purification|January 23, 2016
The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network TrialsJochen G Raimann, Christopher T Chan, John T Daugirdas, et al.
Kidney International|May 17, 2013
JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathyJasmin Divers, Marina Núñez, Kevin P High, et al.
Journal of the American Society of Nephrology : JASN|December 31, 2005
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO studyAlfred K Cheung, Michael V Rocco, Guofen Yan, et al.
Kidney International|May 10, 2016
APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal diseaseLijun Ma, Carl D Langefeld, Mary E Comeau, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2020
Relationship between measured and prescribed dialysate sodium in haemodialysis: a systematic review and meta-analysisJack Kit-Chung Ng, Brendan Smyth, Mark R Marshall, et al.
Pageof 22